REVIVA PHARMACEUTICALS
Reviva Pharmaceuticals is a clinical-stage biopharmaceutical company that discovers, develops and seeks to commercialize next-generation therapeutics for diseases representing significant unmet medical needs and burden to society, patients, and their families. Reviva’s current pipeline focuses on the central nervous system, respiratory, and metabolic diseases. Reviva is using chemical genomics driven technology platform and proprietary chemistry to develop new medicines. Reviva’s pipeline currently has two drug candidates, RP5063 (Brilaroxazine) and RP1208. Both are new chemical entities discovered in-house. Reviva has been granted composition of matter patents for both RP5063 and R1208 in the United States (U.S.), Europe, and several other countries.
REVIVA PHARMACEUTICALS
Industry:
Biopharma Biotechnology Genetics Health Care Pharmaceutical
Founded:
2006-01-01
Address:
San Jose, California, United States
Country:
United States
Website Url:
http://www.revivapharma.com
Total Employee:
11+
Status:
Active
Contact:
+114088161470
Email Addresses:
[email protected]
Total Funding:
41.41 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API WordPress Apache Wordpress Plugins Microsoft Exchange Online IPv6 Cloudflare JS
Similar Organizations
Afferent Pharmaceuticals
Afferent Pharmaceuticals is a clinical-stage biopharmaceutical company that develops medicines to treat chronic pain.
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
American Family Care
American Family Care is a medical practice offering occupational health services.
Arbutus Biopharma
Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Corvus Pharmaceuticals
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.
Deciduous Therapeutics
Deciduous Therapeutics is an aging therapeutics company developing a novel class of immune modulatory therapies.
Eloxx
Eloxx Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel RNA-modulating drug candidates.
Harbour Biomed
Harbour BioMed is a clinical stage biopharmaceutical company developing innovative therapeutics in the fields of immuno-oncology.
Imago Pharmaceuticals
Imago Pharmaceuticals is a virtual, privately held company developing JNK-directed novel therapies.
Jacobio Pharmaceuticals
Jacobio Pharmaceuticals is a clinical-stage pharmaceutical company focusing on the development of innovative oncology and other therapies.
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
Nivalis Therapeutics
Nivalis Therapeutics is a clinical-stage pharmaceutical company developing a novel class of disease modifying therapies.
New River Pharmaceuticals Inc
New River Pharmaceuticals is a specialty pharmaceutical company developing novel pharmaceuticals.
NovaBay Pharmaceuticals
NovaBay Pharmaceuticals is a biopharmaceutical company developing products for the eye care market.
Pacira Pharmaceuticals
Pacira Pharmaceuticals is a specialty pharmaceutical company dedicated to postsurgical innovation.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
Palisade Bio
Palisade Bio is a clinical-stage biopharmaceutical company developing novel therapies for acute and chronic gastrointestinal complications.
Sparrow Pharmaceuticals
Sparrow Pharmaceuticals is a clinical-stage biopharmaceutical company developing treatments for disorders of corticosteroid excess.
Xenon Pharmaceuticals
Xenon Pharmaceuticals operates as a neurology-focused biopharmaceutical company.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Official Site Inspections
http://www.revivapharma.com Semrush global rank: 4.3 M Semrush visits lastest month: 2.67 K
- Host name: 141.193.213.21
- IP address: 141.193.213.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Reviva Pharmaceuticals"
Home - Reviva Pharmaceuticals
Nov 6, 2024 · We are a clinical-stage pharmaceutical company focused on discovering and developing novel therapies for central nervous system, respiratory, and metabolic diseases of …See details»
About us - Reviva Pharmaceuticals
We are a clinical-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), cardiovascular, metabolic, and …See details»
Corporate Presentation - Reviva Pharmaceuticals
Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) corporate presentation.See details»
Reviva Pharmaceuticals - Crunchbase Company Profile …
Reviva Pharmaceuticals is a clinical-stage biopharmaceutical company that discovers, develops and seeks to commercialize next-generation therapeutics for diseases representing significant unmet medical needs and burden to society, …See details»
Reviva Pharmaceuticals - LinkedIn
Reviva is developing a portfolio of internally discovered next generation innovative therapies using chemical genomic driven approaches and proprietary technologies that addresses unmet medical...See details»
Reviva Pharmaceuticals to Participate in The Benchmark …
CUPERTINO, Calif., Nov. 30, 2023 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company …See details»
Reviva Pharmaceuticals Holdings, Inc. (RVPH) - Yahoo Finance
Reviva Pharmaceuticals Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the...See details»
Investors - Reviva Pharmaceuticals
1 day ago · Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) is a clinical-stage pharmaceutical company that discovers, develops and seeks to commercialize next …See details»
Reviva Pharmaceuticals - VentureRadar
Reviva Pharmaceuticals is a privately held, late-stage clinical development pharmaceutical company that is developing a portfolio of internally discovered therapies that address unmet …See details»
Reviva Pharmaceuticals Holdings, Inc. Receives FDA May
Jan 10, 2022 · Reviva is a clinical-stage biopharmaceutical company that discovers, develops and seeks to commercialize next-generation therapeutics for diseases representing unmet medical …See details»
Reviva Pharmaceuticals Announces 80% Global Enrollment Update …
Jun 22, 2023 · Enrollment is ongoing at multiple sites in the United States, Europe, and Asia. “We are very excited that global enrollment has exceeded 80% in our pivotal Phase 3 trial for …See details»
Reviva Pharmaceuticals Holdings, Inc. Announces $8.5
Sep 6, 2022 · Reviva is a clinical-stage biopharmaceutical company that discovers, develops and seeks to commercialize next-generation therapeutics for diseases representing unmet medical …See details»
Reviva Provides Corporate and Program Updates and Highlights …
Jan 4, 2024 · Reviva is a late-stage biopharmaceutical company that discovers, develops, and seeks to commercialize next-generation therapeutics for diseases representing unmet medical …See details»
Reviva Pharmaceuticals - Craft
Aug 9, 2024 · Reviva Pharmaceuticals is a pharmaceutical company. It develops a portfolio of internally discovered therapies that address unmet medical needs in the areas of central …See details»
Reviva Provides Corporate and Program Updates and
Jan 4, 2024 · Reviva is a late-stage biopharmaceutical company that discovers, develops, and seeks to commercialize next-generation therapeutics for diseases representing unmet medical …See details»
Reviva Reports Full Year 2023 Financial Results and Recent …
Apr 15, 2024 · Reviva is a late-stage biopharmaceutical company that discovers, develops, and seeks to commercialize next-generation therapeutics for diseases representing unmet medical …See details»
Reviva Pharmaceuticals Holdings, Inc. (RVPH) - Yahoo Finance
Reviva Pharmaceuticals Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the...See details»
Reviva Pharmaceuticals Provides Update on Clinical
Jul 27, 2022 · Enrollment remains on pace for Reviva’s Phase 3 clinical trial for the treatment of schizophrenia at 15 sites across the US with enrollment set to begin at sites in Europe and …See details»
Reviva Pharmaceuticals Holdings, Inc. (RVPH) - Stock Analysis
6 days ago · Get a real-time Reviva Pharmaceuticals Holdings, Inc. (RVPH) stock price quote with breaking news, financials, statistics, charts and more.See details»
Press Releases - Reviva Pharmaceuticals
5 days ago · CUPERTINO, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) ("Reviva" or the "Company"), a late-stage …See details»